PARAINFLUENZA

Clinical trials for PARAINFLUENZA explained in plain language.

Never miss a new study

Get alerted when new PARAINFLUENZA trials appear

Sign up with your email to follow new studies for PARAINFLUENZA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for vulnerable patients: drug trial targets parainfluenza lung infections

Disease control Recruiting now

This study tests an experimental drug called DAS181 in people with weakened immune systems who have a parainfluenza infection in their lungs. The goal is to see if the drug helps them breathe without extra oxygen and improves survival. About 274 participants will be randomly assi…

Matched conditions: PARAINFLUENZA

Phase: PHASE3 • Sponsor: Ansun Biopharma, Inc. • Aim: Disease control

Last updated May 22, 2026 14:03 UTC

PARAINFLUENZA

Get alerted when new PARAINFLUENZA trials appear

New hope for vulnerable patients: drug trial targets parainfluenza lung infections